1994 Nobel Prize in Physiology or Medicine
Reason for Award
for their discovery of G-proteins and the role of these proteins in signal transduction in cells
Laureates
United States of America
United States of America
Explanation
Cells in our bodies talk to each other, much like sending letters. G-proteins act like the mail carriers that bring those letters inside the cell. When a signal such as a hormone knocks on the cell’s door (a receptor), the G-protein starts moving and tells the inside of the cell, “It’s time to act!” Because of this, our hearts beat faster, sugars are broken down, and many other jobs are done correctly. Drs. Gilman and Rodbell were the first to clearly show how this tiny mail carrier works. Thanks to their discovery, scientists can now design new medicines to help us when we are sick.
Related Keywords
G protein
Proteins that bind and hydrolyze GTP, functioning as molecular switches. They exist as heterotrimeric and monomeric forms. The heterotrimeric type comprises α, β, and γ subunits activated by GPCRs. GTP hydrolysis on the α subunit serves as a timing mechanism to terminate signaling. They are central players in relaying information from numerous hormones and sensory stimuli into the cell.
G protein-coupled receptor (GPCR)
A receptor family with seven transmembrane helices that senses diverse external stimuli such as light, odorants, and hormones. Upon ligand binding it undergoes conformational change and acts as a GEF, exchanging GDP for GTP on G-proteins. About 800 GPCRs exist in humans and constitute over 30 % of drug targets. Recent cryo-EM studies have elucidated many active-state structures. Mutations are linked to cancer and hereditary diseases, underscoring their medical importance.
signal transduction
The process by which external information is converted into intracellular biochemical reactions. It involves multiple steps, including receptors, second messengers, and kinase cascades. G-proteins mediate an early amplification step. Malfunction leads to diseases such as cancer, diabetes, and depression. Understanding it underpins biopharmaceutical research and synthetic biology.
adenylyl cyclase
A membrane-bound enzyme that converts ATP to cAMP. Activated Gsα boosts cAMP levels, regulating transcription and metabolism via PKA. Giα conversely inhibits the enzyme, maintaining balance. Nine isoforms allow tissue-specific responses. It contributes to heart function and memory formation, making it an active pharmacological target.
second messenger
Small molecules or ions that amplify the initial receptor stimulus inside the cell; examples include cAMP, IP3, and Ca2+. G-proteins regulate their production or release. Their concentrations change rapidly and are spatially compartmentalized. Systems biology models the dynamics of second-messenger waves.
GDP/GTP exchange
The switching reaction of a G-protein in which inactive GDP-bound form converts to active GTP-bound form. Receptors or GEFs accelerate the exchange, whereas intrinsic GTPase activity or GAPs terminate the cycle. Modulating exchange rates is key to signal strength. Many disease mutations alter exchange capability. Drugs targeting this reaction are under development.
βγ subunit
The unit that remains together when the heterotrimeric G-protein dissociates. It directly activates ion channels or PI3 kinase, mediating pathways distinct from the α subunit. Membrane localization is controlled by prenylation. Diverse βγ combinations contribute to signal specificity. It is gaining attention as a drug target.
phospholipase C
An enzyme activated by Gqα that hydrolyzes membrane lipid PIP2 into IP3 and DAG. IP3 triggers Ca2+ release, and DAG activates PKC, eliciting diverse cellular responses. Multiple isoforms exist and are essential for fertilization, immune responses, and neurotransmission. Hyperactivity contributes to tumor progression, prompting inhibitor screening.
drug target
Molecules at which drugs exert their therapeutic effect. The GPCR–G-protein system is one of the most successful target groups, with about one-third of existing drugs acting through this pathway. Selective agents can be designed for each ligand or receptor subtype. The concept of biased signaling aims to reduce side effects. Drug discovery using AI and structural data is rapidly advancing.
RGS protein
Short for Regulator of G protein Signaling, these proteins accelerate GTPase activity, terminating signals quickly. About 20 types exist in mammals, with tissue-specific expression fine-tuning response speed. Mutations are linked to hypertension and neurological disorders. Small-molecule inhibitors or stabilizers are being explored for therapy. They are key to understanding temporal and spatial control of G-protein signaling.